TNF and rheumatoid arthritis: To this end, we reviewed already published genomic, transcriptomic and proteomic markers of response and non-response to anti-TNF biological drugs in rheumatoid arthritis and performed a gene ontology analysis to help elucidate biological processes linked to response and non-response to anti-TNF therapy.